Abbott Laboratories (ABT) shares outstanding: 1.73B
Abbott Laboratories had 1.73B shares outstanding on Sep 30, 2026, down 0.4% from 1.74B a year earlier.
From Abbott Laboratories's filings with the SEC · ABT stock page
Abbott Laboratories shares outstanding by year
#47 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Sep 30, 2026 | 1.73B | -0% |
| Sep 30, 2025 | 1.74B | +0% |
| Sep 30, 2024 | 1.73B | -0% |
| Sep 30, 2023 | 1.74B | -0% |
| Sep 30, 2022 | 1.74B | – |
Shares outstanding of similar companies
Companies in the same industry as Abbott Laboratories, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Merck | 2.47B | Oct 31, 2026 |
| Johnson & Johnson | 2.41B | Oct 15, 2026 |
| Bristol Myers Squibb | 2.04B | Oct 21, 2026 |
| AbbVie | 1.77B | Oct 26, 2026 |
| Abbott Laboratories | 1.73B | Sep 30, 2026 |
| BeOne Medicines | 1.48B | Oct 30, 2026 |
| TEVA Pharmaceutical Industries | 1.17B | Sep 30, 2026 |
Questions and answers
What is Abbott Laboratories's shares outstanding?
Abbott Laboratories had 1.73B shares outstanding on Sep 30, 2026, down 0.4% from 1.74B a year earlier.
Numbers as reported in Abbott Laboratories's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology